Literature DB >> 27780009

Very Low Doses of Mycobacterium tuberculosis Yield Diverse Host Outcomes in Common Marmosets (Callithrix jacchus).

Anthony M Cadena1, Edwin C Klein2, Alexander G White1, Jaime A Tomko1, Chelsea L Chedrick1, Douglas S Reed3, Laura E Via4, Philana Ling Lin5, JoAnne L Flynn6.   

Abstract

Identifying and refining small-animal models of tuberculosis that recapitulate aspects of human Mycobacterium tuberculosis infection can contribute to advancing our understanding of critical facets of the disease. To study the effects of very low-dose infections with 2 strains of M. tuberculosis on disease progression and survival in common marmosets, animals were challenged with strains Erdman and CDC1551 at doses ranging from 1 to 12 cfu. These data revealed that the susceptibility of marmosets to M. tuberculosis infection is influenced by strain virulence and initial dose. Marmoset infection with the Erdman strain, even at very low doses, resulted in rapid disease progression associated with severe weight loss, extensive pathology, and poor survival. By contrast, challenge with the less virulent CDC1551 strain resulted in slower disease progression, delayed weight loss, and prolonged survival. One marmoset infected with CDC1551 at a very low dose (approximately 1 cfu) was able to contain and control M. tuberculosis infection in a subclinical state that persisted as long as 300 d. These findings underscore the critical importance of understanding the heterogeneity in host outcome that can arise in association with different infectious doses and strains in the marmoset model of tuberculosis.

Entities:  

Mesh:

Year:  2016        PMID: 27780009      PMCID: PMC5073067     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  21 in total

Review 1.  Understanding latent tuberculosis: a moving target.

Authors:  Philana Ling Lin; Joanne L Flynn
Journal:  J Immunol       Date:  2010-07-01       Impact factor: 5.422

2.  Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.

Authors:  Catherine W M Ong; Paul T Elkington; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

Review 3.  Macrophages and control of granulomatous inflammation in tuberculosis.

Authors:  J L Flynn; J Chan; P L Lin
Journal:  Mucosal Immunol       Date:  2011-03-23       Impact factor: 7.313

4.  PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis.

Authors:  M Teresa Coleman; Ray Y Chen; Myungsun Lee; Philana Ling Lin; Lori E Dodd; Pauline Maiello; Laura E Via; Youngran Kim; Gwendolyn Marriner; Veronique Dartois; Charles Scanga; Christopher Janssen; Jing Wang; Edwin Klein; Sang Nae Cho; Clifton E Barry; JoAnne L Flynn
Journal:  Sci Transl Med       Date:  2014-12-03       Impact factor: 17.956

5.  Different strains of Mycobacterium tuberculosis cause various spectrums of disease in the rabbit model of tuberculosis.

Authors:  Yukari C Manabe; Arthur M Dannenberg; Sandeep K Tyagi; Christine L Hatem; Mark Yoder; Samuel C Woolwine; Bernard C Zook; M Louise M Pitt; William R Bishai
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 6.  Lessons from experimental Mycobacterium tuberculosis infections.

Authors:  JoAnne L Flynn
Journal:  Microbes Infect       Date:  2006-01-18       Impact factor: 2.700

7.  Early Changes by (18)Fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques.

Authors:  M Teresa Coleman; Pauline Maiello; Jaime Tomko; Lonnie James Frye; Daniel Fillmore; Christopher Janssen; Edwin Klein; Philana Ling Lin
Journal:  Infect Immun       Date:  2014-03-24       Impact factor: 3.441

Review 8.  Marmoset models commonly used in biomedical research.

Authors:  Keith Mansfield
Journal:  Comp Med       Date:  2003-08       Impact factor: 0.982

9.  Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing.

Authors:  Philana Ling Lin; Christopher B Ford; M Teresa Coleman; Amy J Myers; Richa Gawande; Thomas Ioerger; James Sacchettini; Sarah M Fortune; JoAnne L Flynn
Journal:  Nat Med       Date:  2013-12-15       Impact factor: 53.440

10.  A critical role for CD8 T cells in a nonhuman primate model of tuberculosis.

Authors:  Crystal Y Chen; Dan Huang; Richard C Wang; Ling Shen; Gucheng Zeng; Shuyun Yao; Yun Shen; Lisa Halliday; Jeff Fortman; Milton McAllister; Jim Estep; Robert Hunt; Daphne Vasconcelos; George Du; Steven A Porcelli; Michelle H Larsen; William R Jacobs; Barton F Haynes; Norman L Letvin; Zheng W Chen
Journal:  PLoS Pathog       Date:  2009-04-17       Impact factor: 6.823

View more
  4 in total

1.  SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts.

Authors:  Amy L Hartman; Sham Nambulli; Cynthia M McMillen; Alexander G White; Natasha Louise Tilston-Lunel; Joseph R Albe; Emily Cottle; Matthew D Dunn; L James Frye; Theron H Gilliland; Emily L Olsen; Katherine J O'Malley; Madeline M Schwarz; Jaime A Tomko; Reagan C Walker; Mengying Xia; Matthew S Hartman; Edwin Klein; Charles A Scanga; JoAnne L Flynn; William B Klimstra; Anita K McElroy; Douglas S Reed; W Paul Duprex
Journal:  PLoS Pathog       Date:  2020-09-18       Impact factor: 6.823

Review 2.  One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics.

Authors:  Hee-Jeong Yang; Decheng Wang; Xin Wen; Danielle M Weiner; Laura E Via
Journal:  Front Cell Infect Microbiol       Date:  2021-03-16       Impact factor: 5.293

3.  SIV and Mycobacterium tuberculosis synergy within the granuloma accelerates the reactivation pattern of latent tuberculosis.

Authors:  Collin R Diedrich; Tara Rutledge; Pauline Maiello; Tonilynn M Baranowski; Alexander G White; H Jacob Borish; Paul Karell; Forrest Hopkins; Jessica Brown; Sarah M Fortune; JoAnne L Flynn; Zandrea Ambrose; Philana Ling Lin
Journal:  PLoS Pathog       Date:  2020-07-30       Impact factor: 6.823

Review 4.  The current state of animal models and genomic approaches towards identifying and validating molecular determinants of Mycobacterium tuberculosis infection and tuberculosis disease.

Authors:  Allison N Bucsan; Smriti Mehra; Shabaana A Khader; Deepak Kaushal
Journal:  Pathog Dis       Date:  2019-06-01       Impact factor: 3.166

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.